Alzheimer's Disease - Dementia
Treatment
NEWS:
Alzheimer Drug Aricept of "Little" Value?
Alzheimer's Drugs Seldom Effective, Researchers Say
Blood Pressure Drugs May Slow Deterioration Of Alzheimer's
Drug for Alzheimer's disease is of little benefit, study shows
People who have early stage Alzheimer's disease could be more capable of learning than previously thought
Studies reveal "disappointing" data on statin therapy for Alzheimer's disease
ARTICLES:
JOURNAL ARTICLES:
A guideline for the treatment of dementia in Japan. (Intern Med)
Acetylcholinesterase inhibition in Alzheimer's Disease. (Curr Pharm Des)
Combination therapy in Alzheimer's disease: a review of current evidence. (CNS Drugs)
[Doubtful evidence for the use of the cholinesterase inhibitor donepezil in patients with dementia - a systematic review.] (Fortschr Neurol Psychiatr)
Effects of Galantamine on Behavioural and Psychological Disturbances and Caregiver Burden in Patients With Alzheimer's Disease (Curr Med Res Opin)
Ginkgo biloba Compared with Cholinesterase Inhibitors in the Treatment of Dementia: A Review Based on Meta-Analyses by the Cochrane Collaboration (Dement Geriatr Cogn Disord)
Hormone therapy and Alzheimer's disease: benefit or harm? (Expert Opin Pharmacother)
Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study. (J Am Geriatr Soc)
Memantine for dementia. (Cochrane Database Syst Rev)
Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress (Molecular Aspects of Medicine)
Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. (J Neurochem)
Pharmacological Management of Alzheimer Disease: An Update (Geriatrics & Aging)
Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey. (Int J Geriatr Psychiatry)
Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. (Neurology)
The Cholinesterase Inhibitors (Journal of Psychiatric Practice:)
The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months (Arch Neurol)
Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions. (Drugs Aging)
Update on Treatment for Alzheimer's Disease--Part 1: Primary Treatments (Clinical Geriatrics)
What is the rationale for new treatment strategies in Alzheimer's disease? (CNS Spectr)
Go to the top
|